GLP-1 15mg

$279.99

GLP-1 15mg — an incretin-receptor research peptide, supplied as lyophilised powder for in vitro and laboratory research. COA-verified purity; certificates of analysis are published on this site. Not for human consumption, clinical, or veterinary use.

Supplied for laboratory research use only. Orders are accepted from research institutions, licensed researchers, universities and laboratory R&D purchasers. Not for human or veterinary use.

Discount per Quantity

Quantity2 - 56 - 78 - 910 +
Discount5%10%15%25%
Price$265.99$251.99$237.99$209.99

15 in stock

Free Shipping over $200

Orders ship within 24 hours

Further reading

Reference articles on identity, analysis and Canadian research-use status. They describe how these materials are characterised, not how they are used.

Description

GLP-1 15mg: Research-Grade GLP‑1 Receptor Agonist Peptide for Receptor signalling & Receptor Pathway Studies

GLP-1 15mg is a high-purity, research-grade peptide designed for laboratory studies on GLP‑1 receptor signaling, peptide–receptor interactions, and receptor pathway research.

This peptide is intended exclusively for controlled scientific investigation. It is not approved for human consumption, clinical use, or therapeutic application.


What is GLP-1?

GLP-1 is a synthetic GLP‑1 receptor agonist peptide. Structurally designed to mimic the endogenous glucagon-like peptide-1 (GLP‑1) hormone, it is widely used in laboratory research investigating:

  • GLP‑1 receptor binding and signaling

  • Peptide–receptor interaction studies

  • Receptor pathway modeling

  • Cellular signaling assays in experimental systems

  • Endocrine system research

The 15mg formulation provides researchers with a larger quantity suitable for multi-phase experimental protocols, dose-response modeling, or extended laboratory studies.


Key Research Applications of GLP-1 15mg

• GLP‑1 Receptor Signaling Research – Examining receptor binding dynamics and peptide signaling mechanisms.
• Peptide–Receptor Interaction Studies – Exploring interactions between synthetic peptides and GLP‑1 receptors.
• Receptor Pathway Investigations – Studying peptide-mediated signaling in receptor signalling research models.
• Endocrine System Research – Controlled experiments on hormone receptor pathways and intracellular signaling.
• Molecular & Cellular Assays – Laboratory investigations into receptor activation and pathway modulation.


Why Choose GLP-1 15mg for Your Research?

GLP-1 15mg is manufactured under strict research-grade standards for purity, consistency, and reproducibility in laboratory settings.

  • High-Purity Manufacturing – Produced using validated peptide synthesis processes.

  • Quality Control & Consistency – Products are tested for identity and purity.

  • Larger Quantity Format – Supports multi-phase or extended research protocols.

  • Research-Only Designation – Intended solely for laboratory and experimental applications.


Quality Assurance & Purity Guarantee

ExoLabz provides a purity testing guarantee for all research peptides. Researchers may verify GLP-1 15mg via independent testing. If the peptide fails to meet stated purity standards, a full refund will be issued and testing costs reimbursed, ensuring confidence in your research material.


Important Legal Disclaimer

For Research Purposes Only

GLP-1 15mg is strictly for laboratory research and scientific investigation. It is not for human consumption, veterinary use, therapeutic application, or clinical use.

This compound has not been approved by the FDA, Health Canada, or any other regulatory authority for medical use.

By purchasing, you confirm that the product will be used solely for lawful laboratory research by qualified professionals in controlled environments.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

  • Willard FS, et al. JCI Insight. 2020;5(17):e140532. In HEK293 and CHO-K1 cells, measured competition radioligand binding, cAMP accumulation, beta-arrestin recruitment and receptor internalisation at human GIPR and GLP-1R. Source · PMID 32730231
  • Zhao F, et al. Nat Commun. 2022;13:1057. Solved five cryo-EM structures of Gs-coupled GIPR, GLP-1R and GCGR at 3.0-3.5 A and measured cAMP potency across site-directed receptor mutants. Source · PMID 35217653
  • Knerr PJ, et al. Mol Metab. 2022;63:101533. Rodent study comparing triagonists with tuned GLP-1R/GIPR/GCGR potency ratios; see the linked record for methods and endpoints. Source · PMID 35809773

Literature notes: References concern receptor pharmacology and preclinical models. Clinical literature is outside the scope of this list.

Browse more compounds in Incretin & Glucagon Peptides, or view the full research peptide catalogue.

Additional information

Weight0.01 kg
Dimensions4.5 × 1.6 × 4.5 cm